Key result
Non-invasive LVFP telemonitoring yields a ~4% HF hospitalization or death rate.
Why the study?
Elevated LVFP typically precedes clinical HF decompensation by days to weeks, and non-invasive remote hemodynamic monitoring enables early detection. Identifying the clinical determinants associated with LVFP elevation during remote monitoring was needed to inform timely intervention before overt clinical deterioration.
Does non-invasive photoplethysmography-based remote hemodynamic monitoring identify clinical determinants of left ventricular filling pressure elevation and reduce heart failure hospitalization and all-cause mortality in patients with NYHA class II–III chronic heart failure?
Does non-invasive photoplethysmography-based remote hemodynamic monitoring identify clinical determinants of left ventricular filling pressure elevation and reduce heart failure hospitalization and all-cause mortality in patients with NYHA class II–III chronic heart failure?
Answers are grounded in this paper and cite their sources.
In chronic heart failure patients undergoing non-invasive remote hemodynamic monitoring, identifiable precipitating triggers—most commonly respiratory infections, medication nonadherence, and arrhythmias—accounted for half of all left ventricular filling pressure elevations across all LVEF phenotypes.
Background Elevated left ventricular filling pressures (LVFP) typically precede clinical heart failure (HF) decompensation by days to weeks. Non-invasive remote hemodynamic monitoring enables early detection of rising LVFP, creating an opportunity for timely intervention before overt clinical deterioration occurs. Purpose To identify clinical determinants associated with LVFP elevation detected during remote monitoring in the STOP-DHF trial. Methods STOP-DHF was a prospective, multicenter, single-arm pragmatic trial enrolling 330 patients with chronic HF (NYHA class II–III), irrespective of left ventricular ejection fraction (LVEF). Non-invasive LVFP was assessed using a CE-certified photoplethysmography-based system. The primary composite event rate of HF hospitalization and all-cause mortality was 4.2% (95% CI 2.3–7.0%), significantly lower than the predefined performance goal of 9% (p < 0.001). Following predefined hemodynamic alerts, structured telephone assessments complemented by medical chart review were performed to evaluate clinical status and identify potential factors associated with LVFP elevation. Precipitating determinants were categorized, and their relative frequencies were analyzed. Results Over a mean follow-up of 6 months, 606 structured medical assessments triggered by LVFP alerts were conducted in 235 patients (mean age 66.6 ± 12.3 years; 36% women; 42% LVEF ≤40%; NYHA II 65%, NYHA III 35%). Thirteen alerts were excluded due to measurement errors, leaving 593 assessments for analysis. An identifiable precipitating factor was present in 300 (51%) cases. Infection was the most frequent determinant (91 cases, 30%), predominantly respiratory (78; 86%). Other contributors included medication nonadherence or recent dose reduction (52; 17%), arrhythmias or conduction disturbances (42; 14%), drug-related factors including NSAID or cardiotoxic medication exposure (39; 13%), and hypertensive episodes (36; 12%). Less common determinants were dietary nonadherence (12; 4%), anemia (8; 3%), myocardial ischemia (3; 1%), and other causes (17; 6%). The distribution of determinants did not differ significantly according to LVEF phenotype (global p = 0.25). Conclusion In this telemonitoring HF cohort, a precipitating clinical factor was identified in approximately half of LVFP alert-triggered assessments, most commonly infection, medication-related factors, and arrhythmias. The similar distribution across HF phenotypes highlights the importance of universal preventive strategies. Non-invasive remote monitoring may enable early recognition of these triggers and facilitate targeted ambulatory interventions to prevent clinical deterioration.
No takes yet. Share an insight, caveat, or question.
BOHM et al. (2026) studied Chronic heart failure (n=330). Non-invasive photoplethysmography-based remote hemodynamic LVFP monitoring with alert-triggered structured assessments vs. Predefined performance goal (9% event rate) was evaluated on Composite of heart failure hospitalization and all-cause mortality (95% CI 2.3-7.0, p=<0.001). Non-invasive LVFP telemonitoring yielded a 4.2% HF hospitalization or death rate, identifying precipitants in 51% of alerts.
Synapse has enriched 10 related papers. Consider them for comparative context: